Fri, 18th Dec 2015 11:15
LONDON (Alliance News) - Physiomics PLC, which aims to streamline the discovery and development of drugs, on Friday said it has raised GBP250,000 by selling new shares.
The company issued 1.00 billion new shares at 0.025 pence each. The stock was trading down 6.3% at 0.0328p on Friday.
The funds raised from the placing will be used for working capital purposes, Physiomics said.
By Samuel Agini; samagini@alliancenews.com; @samuelagini
Copyright 2015 Alliance News Limited. All Rights Reserved.
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Friday and not separately reported...
(Sharecast News) - Physiomics, a mathematical modelling and data science specialist focussed on therapeutics and personalised medicine, has re-engaged...
Physiomics PLC - Abingdon, Oxfordshire-based mathematical modelling and data science for new medicines - Wins new contract from "an existing, large cl...
(Sharecast News) - Data sciences business Physiomics said on Thursday that it has been awarded a new contract by an existing, large client.
Physiomics PLC - Abingdon, Oxfordshire-based mathematical modelling and data science for new medicines - Says it has been awarded a significant contra...
Physiomics (PYC)